MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from issuance of
common stock, net of...
$674,651
Net cash provided by
financing activities
$674,651
Effect of foreign
exchange rates on cash and...
$1,204
Net decrease in cash
and cash...
-$919,734
Canceled cashflow
$675,855
Research and development
tax incentive...
-$418,890
Depreciation and
amortization
$327,367
Accounts receivable
-$261,166
Impairment of long-lived
assets
$243,456
Non-cash adjustment on
r&d expenditure...
-$127,108
Stock-based compensation
$61,575
Accounts payable and
accrued expenses
$45,450
Inventories
-$37,931
Other current assets
-$8,049
Long-term employee
benefit liabilities
$6,885
Proceeds from sale of
assets held for sale
$40,158
Net cash used in
operating activities
-$1,567,515
Canceled cashflow
$1,537,877
Net cash used in
investing activities
-$28,074
Canceled cashflow
$40,158
Net loss
-$2,686,613
something is missing
-$261,853
Non-cash other operating
activities
$115,509
Operating lease
liabilities
-$41,417
Purchase of property and
equipment
$68,232
Back
Back
Cash Flow
source: myfinsight.com
INTELLIGENT BIO SOLUTIONS INC. (INBS)
INTELLIGENT BIO SOLUTIONS INC. (INBS)